Iqvia Holdings Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Iqvia Holdings Inc with three other
companies in this sector in the United States:
Charles River Laboratories International Inc
sales of $1.68 billion
of which 50%
was Discovery And Safety Assessment),
PAREXEL International Corporation
of which 78%
was Clinical Reserach Services), and
PRA Health Sciences Inc
Iqvia Holdings Inc reported sales of $6.88 billion
December of 2016.
increase of 19.9%
versus 2015, when the company's sales were $5.74 billion.
Sales at Iqvia Holdings Inc have increased during each of the previous five years
(and since 2011, sales have increased a total of 59%).
Sales of Research and Development Solutions saw an increase
8.8% in 2016, from
$3.19 billion to $3.47 billion.
Not all segments of Iqvia Holdings Inc experienced an increase in sales in 2016:
sales of Integrated Engagement Services fell 29.9% to $796.00 million.